H.-P. Horny - Institute of Pathology, Ludwig-Maximilians-University

基本信息

浏览量：24

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 103 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Response To Avapritinib In Patients (Pts) With Advanced Systemic Mastocytosis (Advsm) With And Without Prior Midostaurin Therapy

A. M. Vannucchi,D. H. Radia, M. W. Drummond,T. I. George,H-P. Horny, J. Gotlib,M. W. Deininger, W. A. Robinson, A. T. Quiery,P. Bose, E. O. Hexner, E. Winton,

HAEMATOLOGICA（2020）

引用1浏览0引用

Epidemiologic aspects of advanced systemic mastocytosis in Germany

J. Schwaab, Cabral do O. N. Hartmann,M. Jawhar,G. Metzgeroth,N. Naumann,A. Schmid, J. Luebke,A. Fabarius,W. -K. Hofmann,K. Sotlar,H. -P. Horny, J. Panse,

ONCOLOGY RESEARCH AND TREATMENT（2019）

引用0浏览0引用

S830 avapritinib, a potent and selective inhibitor of kit d816v, induces complete and durable responses in patients (pts) with advanced systemic mastocytosis (advsm)

D. Radia,M.W. Deininger, J. Gotlib,P. Bose, M.W. Drummond, E.O. Hexner, W.A. Robinson, A.T. Quiery, E. Winton,T.I. George,H.-P. Horny, R. Oren,

HemaSphereno. S1 (2019): 368-368

引用5浏览0引用

Midostaurin: a magic bullet that blocks mast cell expansion and activation

P Valent, C Akin,K Hartmann,T I George,K Sotlar,B Peter,K V Gleixner, K Blatt,W R Sperr,P W Manley, O Hermine,H C Kluin-Nelemans,

Annals of oncology : official journal of the European Society for Medical Oncology（2017）

引用54浏览0WOS引用

Proposed diagnostic criteria and classification of basophilic leukemias and related disorders

P Valent,K Sotlar,K Blatt,K Hartmann,A Reiter,I Sadovnik,W R Sperr, P Bettelheim,C Akin,K Bauer,T I George,E Hadzijusufovic,

LEUKEMIA（2017）

引用36浏览0WOSNATURE引用

Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells

B Peter,S Bibi,G Eisenwort,B Wingelhofer,D Berger,G Stefanzl, K Blatt,H Herrmann, E Hadzijusufovic,G Hoermann,T Hoffmann, J Schwaab,

LEUKEMIA（2017）

引用19浏览0WOSNATURE引用

Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis

M Jawhar, J Schwaab, D Hausmann, J Clemens, N Naumann, T Henzler,H-P Horny, K Sotlar,S O Schoenberg, N C P Cross, A Fabarius,W-K Hofmann,

Leukemiano. 12 (2016): 2342-2350

引用75浏览0WOSNATURE引用

KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis

M Arock, K Sotlar, C Akin,S Broesby-Olsen,G Hoermann, L Escribano,T K Kristensen, H C Kluin-Nelemans,O Hermine,P Dubreuil,W R Sperr, K Hartmann,

LEUKEMIA（2015）

引用219浏览0WOSNATURE引用

219

Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia

G Wedeh,S Cerny-Reiterer,G Eisenwort,H Herrmann,K Blatt, E Hadzijusufovic,I Sadovnik,L Müllauer,J Schwaab,T Hoffmann,J E Bradner,D Radia,

LEUKEMIA（2015）

引用23浏览0WOSNATURE引用

The epigenetic reader brd4 serves as a novel marker and target in aggressive systemic mastocytosis and mast cell leukemia

Ghaith Wedeh,Sabine Cernyreiterer,Emir Hadzijusufovic,Harald Herrmann,Katharina Blatt,Gregor Eisenwort,Gregor Hoermann,Wolfgang R Sperr,Leonhard Muellauer,Christopher R Vakoc, James E Bradner,H P Horny,

HAEMATOLOGICA（2014）

引用23浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn